Rates of COVID-19 Cases or Deaths by Age Group and Vaccination Status and Booster Dose

data.cdc.gov | Last Updated 30 Jun 2022

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes Webpage: https://covid.cdc.gov/covid-data-tracker/#rates-by-vaccine-status Dataset and data visualization details: These data were posted on June 17, 2022, and reflect cases among persons with a positive specimen collection date through May 21, 2022, and deaths among persons with a positive specimen collection date through April 30, 2022. These data will be updated monthly. Please note that these provisional data are subject to change. Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, Seattle King County (Washington), South Dakota, Tennessee, Texas, Utah, West Virginia and Wisconsin; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 70% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 29 jurisdictions; 28 jurisdictions also reported data on deaths among people who received one or more additional booster dose; and 18 jurisdictions reported cases and deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and current estimates of partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, and include ages 5 years and older from December 5, 2021 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, and include ages 12 years and older from December 26, 2021 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. DOI: http://dx.doi.org/10.15585/mmwr.mm7037e1 Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. DOI:http://dx.doi.org/10.15585/mmwr.mm7104e2

Tags: covid-19 deaths, covid-19 cases, covid-19, covid-19 vaccination, covid-19 breakthrough, covid-19 booster doses

This dataset has the following 22 columns:

Column NameAPI Column NameData TypeDescriptionSample Values
outcomeoutcometextCOVID-19 Case or Death [case; death]
monthmonthtextCalendar month and year corresponding to the MMWR week value [MMM YYYY format; e.g. SEP 2021]
mmwr_weekmmwr_weektextMMWR epidemiological year and week [YYYYWW format; e.g. 202101]
age_groupage_grouptextAge Group [12-17 years; 18-49 years; 50-64 years; 65+ years; all_ages_adj]
vaccine_productvaccine_producttextFDA-authorized COVID-19 vaccine product name [ Janssen; Moderna; Pfizer; all_types (includes Janssen, Moderna, Pfizer and unknown, FDA-approved vaccine product types)]
boosted_with_outcomeboosted_with_outcomenumberWeekly count of individuals vaccinated with a primary series and booster dose with the corresponding outcome
boosted_populationboosted_populationnumberCumulative weekly count of the population vaccinated with a primary series and booster dose
primary_series_only_with_outcomeprimary_series_only_with_outcomenumberWeekly count of individuals vaccinated with a primary series only with the corresponding outcome
primary_series_only_populationprimary_series_only_populationnumberCumulative weekly count of the population vaccinated with a primary series only
unvaccinated_with_outcomeunvaccinated_with_outcomenumberWeekly count of unvaccinated individuals with the corresponding outcome
unvaccinated_populationunvaccinated_populationnumberCumulative weekly estimated count of the unvaccinated population
crude_booster_ircrude_booster_irnumberUnadjusted incidence rate of the corresponding outcome among the population vaccinated with a primary series and booster dose (per 100,000 population)
crude_primary_series_only_ircrude_primary_series_only_irnumberUnadjusted incidence rate of the corresponding outcome among the population vaccinated with a primary series only (per 100,000 population)
crude_unvax_ircrude_unvax_irnumberUnadjusted incidence rate of the corresponding outcome among the unvaccinated population (per 100,000 population)
crude_booster_irrcrude_booster_irrnumberUnadjusted incidence rate ratio (unvaccinated rate : vaccinated with a primary series and booster dose rate)
crude_irrcrude_irrnumberUnadjusted incidence rate ratio (unvaccinated rate : vaccinated with a primary series only rate)
age_adj_booster_irage_adj_booster_irnumberAge-standardized incidence rate of the corresponding outcome among the population vaccinated with a primary series and booster dose (per 100,000 population)
age_adj_vax_irage_adj_vax_irnumberAge-standardized incidence rate of the corresponding outcome among the population vaccinated with a primary series only (per 100,000 population)
age_adj_unvax_irage_adj_unvax_irnumberAge-standardized incidence rate of the corresponding outcome among the unvaccinated population (per 100,000 population)
age_adj_booster_irrage_adj_booster_irrnumberAge-standardized incidence rate ratio (unvaccinated rate : vaccinated with a primary series and booster dose rate)
age_adj_irrage_adj_irrnumberAge-standardized incidence rate ratio (unvaccinated rate : vaccinated with a primary series only rate)
continuity_correctioncontinuity_correctionnumberFlag for whether continuity correction was applied for one or more jurisdictions in the strata [1=Yes, 0=No]. The continuity correction is applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population and prevents incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage.